Search

everythinglearnresearchcommunity

for

Search:↓

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

Anti-cancer drugs are diverse and hard to classify due to their different forms and actions.

Using existing drugs for new purposes can effectively treat infections resistant to multiple antibiotics.

Peptide drugs now target hard-to-reach proteins more effectively and specifically.

Adding a second method to PROTACs could improve cancer treatment.

Drug repurposing can create safer, cheaper treatments by finding new uses for existing drugs.

Nanotechnology improves the effectiveness of medicinal plant compounds in drug delivery.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.